← Open Payments lookup

TODD CLEMENTS: Open Payments

NPI 1275603581 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$816 in 43 payments from 12 companies in 2025. Trend: 2023 $994 · 2024 $826 · 2025 $816

Food & beverage: $816
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$196
Otsuka America Pharmaceutical, Inc.10$164
Takeda Pharmaceuticals U.S.A., Inc.4$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$75
Axsome Therapeutics, Inc.3$70
ABBVIE INC.4$64
Neurocrine BioSciences, Inc.3$57
Collegium Pharmaceutical, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
Vanda Pharmaceuticals Inc.1$17

Products named: REXULTI, INVEGA SUSTENNA, TRINTELLIX, CAPLYTA, Auvelity, VRAYLAR, INGREZZA, SPRAVATO.

Industry payments across AR — which companies pay providers there.